Zimbabwe has declined a major American health deal worth 367 million US dollars (£272m) over five years because of Washington's insistence on confidential biological samples.
The decision was revealed following a internal memorandum from December was leaked, indicating that President Emmerson Mnangagwa deemed the arrangement was "unbalanced".
A government spokesman later stated that the US was demanding access to biological samples for research and commercial gain while refused to share the resulting advantages from any future medical innovations.
"We must now begin the challenging and unfortunate process of winding down our health assistance in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont publicly.
Her embassy indicated the United States had donated more than $1.9bn for health programmes to Zimbabwe during the past two decades.
A medical body in Zimbabwe has urged continued dialogue to reach a deal suitable to all parties so the nation's vital HIV treatment initiative can continue.
Broader Context
Zimbabwe's decision comes after a comparable case in Kenya, where a court suspended a related deal with the US following legal challenges were filed about the security of Kenyans' health data.
After returning to the presidency recently, US President Donald Trump has drastically cut overseas assistance and shut down the US Agency for International Development (USAID).
The agency had overseen aid for the US government, but Trump argued its expenditure was "inefficient" and his government was seeking direct bilateral deals to boost openness and responsibility.
As per reports, Sixteen nations in Africa have to date signed similar agreements, representing over $18.3bn in committed funds.
Specifics of the Declined Agreement
The funds for Zimbabwe was intended to supported "combating HIV/Aids, tuberculosis, malaria, maternal and child health, and preparing for epidemics".
"It is our view this partnership might have yielded immense advantages for the people of Zimbabwe, especially the 1.2 million men, women and children presently on HIV treatment via US-supported initiatives," the Ambassador added.
However, government spokesperson Nick Mangwana argued the arrangement was "asymmetrical".
"The proposal required Zimbabwe to provide its biological resources and data indefinitely, without any corresponding assurance of access to any scientific breakthroughs – such as new medicines or tests – that could be developed from that shared data," Mangwana explained.
"Effectively, our country would provide the raw materials for scientific discovery without any assurance that the final treatments would be available to our population should a future pandemic emerge."
National Interest and Global Health
Mangwana further said that the American exit from the global health body and its push of one-on-one deals were upending structures previously established through the international organization.
Mangwana gave as an example its Pathogen Access and Benefit Sharing scheme created to deal with future global health emergencies.
"This framework is intended to ensure that when a country provides its information, the benefits – including vaccines and treatments – are shared equitably, not commercialised solely by those with the capability to develop them."
These objections over the US deal "must not be interpreted as opposition to America," he added.
"We are open to continued dialogue with our US partners on how future co-operation might be arranged in a way that honours the independence and dignity of each country."
Medical Community Reaction
Medical experts stated it acknowledged the official position, but urged that talks should continue given that much of the nation's HIV programmes depended on foreign aid.
"In cases where technical issues arise, including those relating to information security or implementation frameworks, these can frequently be addressed through technical clarification and negotiated safeguards," it commented.
The situation underscores the ongoing challenges between receiving vital international aid and safeguarding national sovereignty in an increasingly interconnected world.